Asia Pacific Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds), By End-use (Hospitals, Specialty Clinics), By Country, And Segment Forecasts, 2024 - 2030

APAC Advanced Wound Care Market Trends

The Asia Pacific advanced wound care market size was estimated at USD 1.72 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030. Major factors contributing to the market growth are the increasing demand for reducing hospital stays, the rising incidence of chronic wounds, and the rising number of surgeries in the region. The increasing incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is anticipated to increase the incidence rate of chronic wounds in Asia Pacific.

The increasing demand to decrease hospital stays in the Asia Pacific is propelling growth in the wound care market through several mechanisms. As healthcare costs rise and governments emphasize cost-effective healthcare delivery, there's a concerted effort to adopt wound care products that expedite healing and minimize the need for prolonged hospitalization. Technological advancements in infection care, including advanced dressings and negative pressure wound therapy systems, enable healthcare providers to manage injuries outside traditional hospital settings effectively. For instance, in September 2022, MIMEDX Group, Inc., developer of placental biologics, received approval from the Japanese Ministry of Health, Labour and Welfare (JMHLW) to reimburse EPIFIX. This approval signifies a significant milestone in treating refractory or difficult-to-heal lower extremity diabetic and venous ulcers. EPIFIX offers a transformative solution for patients suffering from these debilitating conditions by leveraging advanced placental biologics technology.

The increasing incidence of chronic injuries is a driving force behind propelling the market. With factors like aging populations, lifestyle changes, and the prevalence of chronic conditions such as diabetes and obesity on the rise in the region, there's a corresponding increase in the occurrence of chronic infections like diabetic foot ulcers and pressure ulcers. These infections often necessitate specialized and advanced wound care treatments to facilitate healing and prevent complications. For instance, according to the World Health Organization (WHO), China is experiencing one of the most rapid increases in its elderly population globally, with projections indicating that by 2040, individuals over 60 will constitute 28% of the population, driven by extended life expectancy and declining birth rates. This demographic transformation presents challenges and prospects for public health and socioeconomic progress, particularly in establishing an inclusive system addressing older people's health and social requirements, ensuring equitable healthcare access irrespective of geographic location.

The rising number of surgeries across the region is one of the primary factors for propelling the growth of the global advanced wound care market. As healthcare infrastructure expands and access to surgical interventions improves, there is a parallel increase in post-operative injury management requirements. Surgical procedures, ranging from elective surgeries to complex interventions, often necessitate advanced wound management solutions to facilitate optimal healing and reduce the risk of complications. This surge in surgical interventions, coupled with the rising prevalence of chronic diseases and age-related conditions, underscores the growing demand for advanced infection care products and therapies such as bioactive dressings, negative pressure wound therapy, and cellular and tissue-based treatments. For instance, according to the Janssen Asia Pacific, the region accounts for half of the globe's new cancer diagnoses, with a projected 36% rise in cancer-related deaths by 2030. The region boasts the highest occurrence rates of liver and stomach cancers worldwide, while prostate cancer has emerged as a prominent male cancer in select Asian nations.

Market Concentration & Characteristics

Market growth stage is medium, and pace of the market growth is accelerating. The market's high degree of innovation is driven by the technological advancements, increasing demand for effective wound management solutions, and a growing focus on research and development to address the region's diverse healthcare needs. For instance, in October 2023, DuPont announced DuPont Liveo MG 7-9960, a novel silicone soft skin adhesive (SSA) tailored for advanced wound care and long-term medical device attachment, boasting enhanced adhesion and minimized cyclic properties, addressing the need for improved adhesion and patient comfort.

The market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players. This is due to several factors such as strategic expansion initiatives, efforts to broaden product portfolios, and the pursuit of partnerships to enhance market competitiveness. These M&A activities enable companies to capitalize on emerging opportunities, consolidate market presence, and leverage complementary strengths to address evolving customer demands effectively.

The market is also subject to increasing regulatory scrutiny. This is due to concerns for the need to ensure patient safety, product efficacy, and compliance with evolving standards and regulations across different countries in the region. As the demand for advanced wound care solutions grows, regulatory bodies are intensifying their oversight to uphold quality standards, assess product safety, and monitor advertising and labeling practices to safeguard patient welfare and promote transparency within the industry. For instance, in January 2024, Avanos Medical, Inc. recalled specific lots of MIC Gastric - Jejunal Feeding Tube Kits due to potential sterility issues in the Nurse Assist supplied pre-filled syringes, which may risk infection if non-sterile water contacts surgical sites, affecting the feeding tube's inflation.

Advanced wound care substitutes encompass alternative therapies such as traditional injury dressings, home remedies, and natural treatments, offering different approaches to trauma management. According to the National Center for Biotechnology Information, Chronic infections such as diabetic foot ulcers and venous leg ulcers impose a substantial strain on healthcare systems. They can have 5-year mortality rates similar to cancer, profoundly affecting patients' well-being with symptoms including pain, odor, reduced mobility, and social withdrawal. Skin substitutes, advanced treatments indicated for non-responsive injuries, should be selected based on evidence, which varies depending on wound causes, with over 75 substitutes currently accessible and continuing to increase in number.

End-user concentration is a significant factor in the Asia Pacific market. End-user concentration in the market refers to the distribution of market share among hospitals, home healthcare settings, and specialty clinics, with hospitals being the primary end-users, followed by home healthcare agencies, collectively shaping demand patterns and market dynamics.

Product Insights

Based on product, the moist segment led the market with the largest revenue share of 70.9% in 2023. The market is segmented by product into moist, antimicrobial, and active products. The moist segment is further segmented into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and other advanced dressings. This high percentage can be attributed to an increasing geriatric population in many Asian countries, coupled with rising incidences of chronic diseases such as diabetes, which has led to a higher prevalence of chronic injuries that require advanced wound care solutions, including moist products. For instance, in October 2022, Healthium Medtech (Apax Partners), a provider of medical devices specializing in surgical, post-surgical, and chronic care solutions, introduced its injuries dressing collection, TheruptorTM Novo. Specifically designed for treating chronic diseases such as diabetic foot ulcers and leg ulcers, this portfolio enhances Healthium's already robust lineup of patented products in the advanced wound dressing sector.

The active segment is expected to grow at the fastest CAGR of 7.12% over the forecast period. The active segment is further segmented into biomaterials, skin-substitute, and growth factors. The advancements in healthcare infrastructure and rising healthcare expenditure in countries across the region have facilitated greater access to advanced wound care products, including active infection dressings, which offer benefits such as faster healing and reduced risk of infection. For instance, medical care costs in the Asia Pacific rose from 7.2% in 2022 to a high of 9.9% in 2023, indicated by the WTW Global Medical Trends Survey, with expectations for the insurer-reported cost trend to plateau at 9.9% in 2024, reflecting stability impacted by regional market variations, where some areas experience minimal changes while others show slight fluctuations in costs from 2023 to 2024.

Application Insights

Based on application, the chronic wounds segment accounted for the largest market revenue share in 2023. The market is segmented by application into chronic wounds and acute wounds. The chronic wounds segment is further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. This is attributable to the technological advancements, encompassing a range of solutions, such as advanced injuries dressings, negative pressure wound therapy systems, products, and topical oxygen therapy devices, among others. These technologies offer improved efficacy, enhanced infection healing outcomes, and greater patient comfort than traditional trauma care methods. In addition, advancements in telemedicine and remote monitoring technologies enable healthcare providers to deliver timely interventions and personalized care to patients with infections, further driving regional market growth. For instance, in November 2023, in South Korea, the NATROX O₂ topical oxygen therapy device, engineered by Inotec AMD—a spinout from Cambridge University—was launched. The device received approval from the Korean Ministry of Food & Drug Safety (MFDS) for shipment and sale within the country. Kove, serving as its distribution partner in South Korea, was expected to oversee its market introduction. Smaller in size than an iPhone, the device employs oxygen to promote infection healing by delivering continuous topical oxygen therapy (cTOT), offering a non-invasive and comfortable solution primarily designed to aid in healing chronic wounds.

The acute wounds segment is expected to grow at the fastest CAGR over the forecast period. The acute wounds segment is further segmented into surgical & traumatic wounds and burns. The integration of artificial intelligence (AI) is a significant driving force behind the growth of the segment, AI-powered telemedicine platforms facilitate remote injury monitoring and consultation, improving access to specialized trauma care expertise, particularly in remote or underserved areas. The integration of AI enhances clinical decision-making and patient outcomes and drives efficiency and cost-effectiveness in infection management across the region. For instance, in June 2023, Singaporean researchers created a wearable infection health monitoring patch called PETAL, which utilizes AI to detect deteriorating injury conditions and alert medical staff for timely intervention. This innovative wearable technology, developed collaboratively by scientists from the National University of Singapore (NUS) and the Agency for Science, Technology, and Research (A*STAR), aims to enhance burns care management.

End-use Insights

Based on end-use, the hospitals segment held the largest market share in terms of revenue in 2023. The market is segmented by end-use into hospitals, specialty clinics, home healthcare, and others. This is attributable to the higher incidence of chronic diseases such as diabetes and cardiovascular conditions. Since older individuals are more prone to injuries, hospitals experience a surge in patients requiring advanced wound care, leading to increased adoption of advanced wound care products and treatments. According to the Agency for Science, Technology and Research (A*STAR), chronic infections afflict approximately 2-6% of populations in developed nations, constituting a substantial economic burden on healthcare systems. In Australia, they account for 2% of the total national health expenditure, while in Wales, they represent 5.5% of NHS spending. The management of injuries incurs significant costs, encompassing expenses related to frequent consultations and dressing changes by healthcare providers. This burden is anticipated to escalate with demographic shifts, including an aging population and a rising prevalence of conditions such as diabetes and obesity in Singapore. As such, there is a pressing need for effective strategies to address the growing impact of trauma on healthcare resources and patient well-being.

The home healthcare is projected to grow at the fastest CAGR over the forecast period owing to the factors such as the technological advancements in the market eventually leading to the market growth. For instance, in October 2021, a groundbreaking development by researchers at the National University of Singapore (NUS) created a smart bandage capable of identifying multiple biomarkers for onsite monitoring of injuries. Collaborating with clinical experts from Singapore General Hospital, the team introduced a wearable sensor that facilitates real-time assessment of infections at the point of care, transmitting data wirelessly to a dedicated app. This innovative sensor technology can swiftly detect temperature, pH levels, bacterial presence, and specific inflammatory factors associated with traumas, providing rapid and precise wound evaluation within a mere 15-minute timeframe.

Country Insights

The advanced wound care market in Asia Pacific held a market with the largest revenue share in 2023, this share is attributable to the rising geriatric population in the region, the rising incidence of injuries and burns, and the rising number of surgeries in the region. The increasing incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is anticipated to increase the incidence rate of chronic wounds in Asia Pacific. For instance, in January 2022, Wounds Australia offered a solution fund totaling USD 2 million to be allocated over four years. This fund aims to establish a nationwide media and digital initiative focused on chronic wound prevention and treatment, leveraging the platform provided by Wound Awareness Week.

Japan Advanced Wound Care Market Trends

The Japan advanced wound care market accounted with a revenue share of 2.6% in 2023. This growth owes to the significantly increasing investments and opportunities growing in the market. For instance, in October 2023, Medical Japan Tokyo an event attracting medical professionals, manufacturers, medical institutions, and research units worldwide. Among the participants, AMS BioteQ marked its debut at the exhibition; the company specializes in the microbial sector, particularly focusing on addressing antibiotic resistance issues. Leveraging its patented biotechnological process, ExtrO, the company successfully engineered various technologies and products, including an innovative natural antibacterial material known as MediAce, which shows potential in facilitating the wound healing process.

Key Asia Pacific Advanced Wound Care Company Insights

Some of the key players operating in the market include 3M, Smith & Nephew, Baxter, and Cardinal Health.

• Smith & Nephew is a medical technology firm specializing in developing, manufacturing, and marketing medical devices for orthopedic reconstruction, trauma, sports medicine, ENT, and advanced wound management. Their product range includes knee and hip implants, robotics-assisted technologies, trauma-related products for fracture stabilization, soft tissue repair instruments, and wound care products catering to surgeons, nurses, physicians, and healthcare purchasers in hospitals and insurance networks

• 3M manufactures and supplies industrial products and solutions across diverse sectors. Their product portfolio encompasses display systems, advanced materials, office supplies, home improvement, personal safety equipment, roofing materials, and more. In addition, 3M provides solutions in medical, oral care, consumer health, food safety, and health information systems, catering to various industries, including automotive, electronics, healthcare, safety, energy, and consumer goods

Mölnlycke Health Care AB, ConvaTec Inc., and Integra LifeSciences Corporation are some of the other market participants in the Asia Pacific market.

• ConvaTec Inc. provides diverse medical products and technologies, catering to various healthcare needs, including wound care, continence management, and infusion therapy, servicing hospitals, home care agencies, and retail distributors globally

• Integra LifeSciences Corporation is a medical technology firm specializing in engineered collagen-based products, including surgical instruments, wound care, orthopedic hardware, implants, dermal regeneration products, and neurosurgery devices. Its solutions cater to orthopedic extremity surgery, neurosurgery, reconstructive, and general surgery, serving various healthcare settings such as hospitals, outpatient centers, and medical practices

Recent Developments

• In January 2023, MiMedx Group, Inc., a prominent player in placental biologics, secured an exclusive distribution deal with Gunze Medical Limited, a subsidiary of Gunze Limited, for the distribution of EPIFIX in Japan, leveraging Gunze Medical's expertise in distributing a variety of wound and surgical products, including bioabsorbable devices and materials

• In September 2022, Smith & Nephew, a medical technology company, launched the RENASYS Negative Pressure Wound Therapy (NPWT) System and VERSAJET Hydrosurgery System in Japan, approved by the Ministry of Health, Labour and Welfare of Japan, enhancing their portfolio of wound management solutions available in the country and aiming to minimize both the human and economic burdens associated with wounds. These new advanced products expand Smith & Nephew's offerings in Japan, providing innovative solutions to address wound management needs and improve patient outcomes

• In November 2021, Smith & Nephew announced the opening of its Medical Education Centre in Singapore, aiming to enhance customer support and healthcare professional development throughout the Asia Pacific region. The strategically positioned center will emphasize digital and robotic surgery training, showcasing Smith & Nephew's Real Intelligence products. It will offer comprehensive training across orthopedic, sports medicine, ENT, and advanced wound management portfolios

Asia Pacific Advanced Wound Care Market Report Scope

APAC Advanced Wound Care Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Asia Pacific advanced wound care market report based on product, application, end-use, and country:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Moist

    • Foam Dressings

    • Hydrocolloid Dressings

    • Film Dressings

    • Alginate Dressings

    • Hydrogel Dressings

    • Collagen Dressings

    • Other Advanced Dressings

  • Antimicrobial

    • Silver

    • Non-silver

  • Active

    • Biomaterials

    • Skin-substitute

    • Growth Factors

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Chronic Wounds

    • Diabetic Foot Ulcers

    • Pressure Ulcers

    • Venous Leg Ulcers

    • Other Chronic Wounds

  • Acute Wounds

    • Surgical & Traumatic Wounds

    • Burns

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Specialty Clinics

  • Home Healthcare

  • Others

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand